Page last updated: 2024-12-07

quinine hydrochloride

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Cross-References

ID SourceID
PubMed CID91558
CHEMBL ID588046
SCHEMBL ID184367
MeSH IDM0018348

Synonyms (54)

Synonym
7549-43-1
fema no. 2976
cinchonan-9-ol, 6'-methoxy-, monohydrochloride, (8alpha,9r)-
quinine monohydrochloride
einecs 205-001-1
quinine chloride
quinine, monohydrochloride
(8alpha,9r)-6'-methoxycinchonan-9-ol monohydrochloride
quinine muriate
cinchonan-9-ol, 6'-methoxy-, monohydrochloride, (8-alpha,9r)-
cinchonan-9-ol, 6'-methoxy-, monohydrochloride, dihydrate, (8alpha,9r)-
ccris 2002
chinimetten
quinine hydrochloride
ai3-62121
6'-methoxycinchonan-9-ol monohydrochloride, (8alpha,9r)-
130-89-2
TCMDC-125479
TCMDC-123484
CHEMBL588046
anhydrous quinine hydrochloride
quinine hydrochloride anhydrous
quinini hydrochloridum
7cs0wno31m ,
unii-7cs0wno31m
chinine hydrochloride
cinchonan-9-ol, 6'-methoxy-, hydrochloride (1:1), (8alpha,9r)-
quinine, hydrochloride
cinchonan-9-ol, 6'-methoxy-, hydrochloride (1:?), (8alpha,9r)-
cinchonan-9-ol, 6'-methoxy-, hydrochloride, (8alpha,9r)-
einecs 231-437-7
AKOS016002029
quinine hydrochloride [who-dd]
quinine hydrochloride [fhfi]
quinine monohydrochloride anhydrous
quinine hydrochloride anhydrous [mi]
(8.alpha.,9r)-6'-methoxycinchonan-9-ol hydrochloride
cinchonan-9-ol, 6'-methoxy-, hydrochloride, (8.alpha.,9r)-
SCHEMBL184367
DTXSID7044213
quinine hydrochloride (1:1)
LBSFSRMTJJPTCW-DSXUQNDKSA-N
mfcd00078498
AS-70722
cinchonan-9-ol, 6'-methoxy-, monohydrochloride, (8?,9r)- (9ci); quinine, monohydrochloride (8ci); chinimetten; chinine hydrochloride; quinine hydrochloride; quinine muriate
(r)-(6-methoxyquinolin-4-yl)((1s,2s,4s,5r)-5-vinylquinuclidin-2-yl)methanol hydrochloride
(r)-[(2s,4s,5r)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl](6-methoxyquinolin-4-yl)methanol hydrochloride
6'-methoxycinchonan-9-ol hydrochloride
quininehcl
(r)-[(2s,4s,5r)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol;hydrochloride
(r)-(6-methoxyquinolin-4-yl)((2s,4s,5r)-5-vinylquinuclidin-2-yl)methanol hydrochloride
A51181
Q27268091
EN300-7357005

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
"Water-soluble prodrug strategy is a practical alternative for improving the drug bioavailability of sparingly-soluble drugs with reduced drug efficacy."( Novel prodrugs with a spontaneous cleavable guanidine moiety.
Hamada, Y, 2016
)
0.43
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (17)

Assay IDTitleYearJournalArticle
AID285334Growth inhibition after 72 hrs of Plasmodium falciparum D6 by HRPII ELISA2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Comparison of a SYBR green I-based assay with a histidine-rich protein II enzyme-linked immunosorbent assay for in vitro antimalarial drug efficacy testing and application to clinical isolates.
AID285332Growth inhibition after 72 hrs of Plasmodium falciparum 3D7 by HRPII ELISA2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Comparison of a SYBR green I-based assay with a histidine-rich protein II enzyme-linked immunosorbent assay for in vitro antimalarial drug efficacy testing and application to clinical isolates.
AID1135022Antimalarial activity against Plasmodium falciparum Vietnam Smith in po once daily dosed Owl monkey assessed as curative dose compound treated for 7 days1979Journal of medicinal chemistry, Oct, Volume: 22, Issue:10
Folate antagonists. 15. 2,3-Diamino-6-(2-naphthylsulfonyl)quinazoline and related 2,4-diamino-6-[(phenyl and naphthyl)sulfinyl and sulfonyl]quinazolines, a potent new class of antimetabolites with phenomenal antimalarial activity.
AID1135024Antimalarial activity against Plasmodium vivax VietnamPalo Alto in po once daily dosed Owl monkey assessed as curative dose compound treated for 7 days1979Journal of medicinal chemistry, Oct, Volume: 22, Issue:10
Folate antagonists. 15. 2,3-Diamino-6-(2-naphthylsulfonyl)quinazoline and related 2,4-diamino-6-[(phenyl and naphthyl)sulfinyl and sulfonyl]quinazolines, a potent new class of antimetabolites with phenomenal antimalarial activity.
AID285335Growth inhibition after 72 hrs of Plasmodium falciparum W2 by SYBR green I assay2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Comparison of a SYBR green I-based assay with a histidine-rich protein II enzyme-linked immunosorbent assay for in vitro antimalarial drug efficacy testing and application to clinical isolates.
AID1135017Antimalarial activity against chloroquine-sensitive, pyrimethamine-resistant Plasmodium falciparum Malayan Camp CH/Q infected in Aotus monkey assessed as dose required to >50% cures compound treated for 7 days1979Journal of medicinal chemistry, Oct, Volume: 22, Issue:10
Folate antagonists. 15. 2,3-Diamino-6-(2-naphthylsulfonyl)quinazoline and related 2,4-diamino-6-[(phenyl and naphthyl)sulfinyl and sulfonyl]quinazolines, a potent new class of antimetabolites with phenomenal antimalarial activity.
AID285333Growth inhibition after 72 hrs of Plasmodium falciparum D6 by SYBR green I assay2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Comparison of a SYBR green I-based assay with a histidine-rich protein II enzyme-linked immunosorbent assay for in vitro antimalarial drug efficacy testing and application to clinical isolates.
AID1135023Antimalarial activity against Plasmodium vivax New Guinea Chesson in po once daily dosed Owl monkey assessed as curative dose compound treated for 7 days1979Journal of medicinal chemistry, Oct, Volume: 22, Issue:10
Folate antagonists. 15. 2,3-Diamino-6-(2-naphthylsulfonyl)quinazoline and related 2,4-diamino-6-[(phenyl and naphthyl)sulfinyl and sulfonyl]quinazolines, a potent new class of antimetabolites with phenomenal antimalarial activity.
AID285336Growth inhibition after 72 hrs of Plasmodium falciparum W2 by HRPII ELISA2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Comparison of a SYBR green I-based assay with a histidine-rich protein II enzyme-linked immunosorbent assay for in vitro antimalarial drug efficacy testing and application to clinical isolates.
AID1287908Solubility of the compound in water at room temperature after 15 mins by HPLC analysis2016Bioorganic & medicinal chemistry letters, Apr-01, Volume: 26, Issue:7
Novel prodrugs with a spontaneous cleavable guanidine moiety.
AID1135018Antimalarial activity against chloroquine-resistant, pyrimethamine-sensitive Plasmodium falciparum Vietnam Oak Knoll in Aotus monkey assessed as dose required to >50% cures compound treated for 7 days1979Journal of medicinal chemistry, Oct, Volume: 22, Issue:10
Folate antagonists. 15. 2,3-Diamino-6-(2-naphthylsulfonyl)quinazoline and related 2,4-diamino-6-[(phenyl and naphthyl)sulfinyl and sulfonyl]quinazolines, a potent new class of antimetabolites with phenomenal antimalarial activity.
AID1135021Antimalarial activity against Plasmodium falciparum Vietnam Oak Knoll in po once daily dosed Owl monkey assessed as curative dose compound treated for 7 days1979Journal of medicinal chemistry, Oct, Volume: 22, Issue:10
Folate antagonists. 15. 2,3-Diamino-6-(2-naphthylsulfonyl)quinazoline and related 2,4-diamino-6-[(phenyl and naphthyl)sulfinyl and sulfonyl]quinazolines, a potent new class of antimetabolites with phenomenal antimalarial activity.
AID285331Growth inhibition after 72 hrs of Plasmodium falciparum 3D7 by SYBR green assay2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Comparison of a SYBR green I-based assay with a histidine-rich protein II enzyme-linked immunosorbent assay for in vitro antimalarial drug efficacy testing and application to clinical isolates.
AID697852Inhibition of electric eel AChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID529905Antiplasmodial activity against Plasmodium falciparum harboring K1 allele group of msp1, 3D7 allele group of msp2 gene and 94 bp of 7A11, 196bp of C4M79 and 336bp of C4M69 locus measured on day 23 by [3H]hypoxanthine incorporation assay2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
First case of emergence of atovaquone-proguanil resistance in Plasmodium falciparum during treatment in a traveler in Comoros.
AID1135020Antimalarial activity against Plasmodium falciparum Malayan Camp CH/Q infected in po once daily dosed Owl monkey assessed as curative dose compound treated for 7 days1979Journal of medicinal chemistry, Oct, Volume: 22, Issue:10
Folate antagonists. 15. 2,3-Diamino-6-(2-naphthylsulfonyl)quinazoline and related 2,4-diamino-6-[(phenyl and naphthyl)sulfinyl and sulfonyl]quinazolines, a potent new class of antimetabolites with phenomenal antimalarial activity.
AID697853Inhibition of horse BChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (20.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (20.00%)4.05%
Observational0 (0.00%)0.25%
Other4 (80.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]